Miltefosine gel for cutaneous leishmaniasis: a pilot study
Treatments studied
Part of Infections, Skin clinical trials.
This study tests a gel form of miltefosine applied directly to skin sores caused by leishmaniasis. It is for adults with mild to moderate skin infections who have not already tried and failed other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old.
- You need a confirmed diagnosis of cutaneous leishmaniasis (a skin infection from sandfly bites).
- You must have 1 to 4 skin sores that are each 1–4 cm wide, have been present for more than a month, and are not on your face, ears, or joints.
- You cannot have severe or complicated leishmaniasis (like large swollen lymph nodes, sores all over your body, or infection in your nose or mouth).
- You must not have had any leishmaniasis treatment (oral or injected) in the last 8 weeks, and you must not have failed previous local or systemic therapy.
- If you are a woman who can get pregnant, you must agree to use birth control until 45 days after treatment ends. You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
This trial tests whether injecting the antibiotic levofloxacin directly into sores caused by Leishmania parasites can help heal them. It might be an option if you have a few sores and haven't recently been treated for this infection.
This study tests if an injection of the antibiotic metronidazole directly into skin sores can help heal leishmaniasis, a parasite infection from sandfly bites. It's for people with fewer than seven sores.
This study tests whether an injection of ciprofloxacin (an antibiotic) directly into skin sores can treat cutaneous leishmaniasis as effectively as the standard medicine, sodium stibogluconate. It may be an option if you have a small number of sores and have not been treated recently.
This trial tests how well miltefosine works for people with leishmaniasis, a skin infection from a parasite. It aims to find the best way to use this medicine to help patients get better.
This study tests different drugs to find which works best for cutaneous leishmaniasis (a skin infection from a parasite). It may help people with many or large sores, or sores in sensitive areas like near the eyes or nose.
Hear when a new Cutaneous Leishmaniasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.